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Abstract
In this chapter, we report and discuss the current literature of nutrient-deficiency anemia, 
also called nutritional anemia, in elderly patients in developed countries. For this purpose, 
a review of medical literatures was conducted searching PubMed, textbooks of hematol-
ogy, internal medicine and geriatrics, and information collected from international meetings 
were also included. The term nutrient deficiency or nutritional anemia covers any anemia, 
defined by a hemoglobin level <13 g/dL (<130 g/L) in men and <12 g/dL (<120 g/L) in women, 
resulting from a deficiency of materials essential for erythropoiesis. Patients with nutritional 
anemia often have mild to moderate anemia, with hemoglobin levels between 8 and 10 g/dL 
(80 and 100 g/L). In practice, nutritional anemia represents one-third of all anemia in elderly 
patients. About two-third of nutritional anemia is associated with iron deficiency and most 
of those cases are the result of chronic blood loss from gastrointestinal lesions. The remain-
ing cases of nutritional anemia are usually associated with vitamin B12 (cobalamin), most 
frequently related to food-cobalamin malabsorption (especially in case of atrophic gastritis), 
and Biermer’s disease (pernicious anemia); and/or vitamin B9 (folate) deficiency, most fre-
quently related to inadequate dietary intake or malnutrition, several drugs (as methotrexate, 
cotrimoxazole) and chronic alcohol intake. In clinical practice, recognition of these disorders 
and deficiencies is essential for optimal treatment (nutrient-deficiency replacement).
Keywords: nutritional anemia, nutrient-deficiency anemia, iron deficiency, vitamin B12 
deficiency, cobalamin deficiency, vitamin B9 deficiency, folate deficiency, food
1. Introduction
Anemia is a common condition, especially in elderly patients (≥75 years) and its prevalence 
increases with age [1]. Anemia affects quality of life in all elderly patients. It also affects cogni-
tive and physical function, especially in frailty patients, and be a factor of aggravation or poor 
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prognosis of chronic diseases, e.g., chronic heart failure (CHF), chronic obstructive pulmonary 
disease (COPD), chronic renal failure, cerebrovascular disorders [2, 3]. Anemia is even associ-
ated with a risk of death. Thus, it should not be accepted as an unavoidable condition or a 
consequence of aging.
In the elderly, many underlying conditions can lead to anemia such as chronic diseases, renal 
failure, myelodysplastic syndromes, cancer, and unexplained anemia. However, the most 
common nutrient deficiencies are iron, vitamin B9 (folic acid), and vitamin B12 (cobalamin) 
deficiency [4]. In clinical practice, recognition of these disorders and deficiencies is essential 
for optimal treatment.
In this chapter, we report and discuss the current literatures of nutrient-deficiency anemia, 
also called nutritional anemia, in elderly patients in developed countries.
2. Bibliographic search strategy
A review of the medical literatures was conducted to identify original studies and review 
articles concerning nutrient-deficiency anemia in elderly patients. In March 2017, PubMed 
was searched for English- and French-language articles. The terms used for online bib-
liographic search included “nutrient-deficiency anemia,” “nutritional anemia,” “iron 
deficiency,” “vitamin B9 deficiency,” “folate deficiency,” “vitamin B12 deficiency” or 
“cobalamin deficiency,” and “elderly patients.” A total of more than 500 abstracts related 
to clinical trial and reviews were identified between the years 2007 and 2017. All of the 
abstracts were reviewed by at least two senior researchers. Only 245 publications were 
eventually retained and 39 publications were used for this review. These publications 
have been selected because of the quality or the originality of the text, the excellence of the 
adopted methodology, and the reputation of the authors.
Textbooks of hematology, internal medicine and geriatrics, and information collected from 
international meetings were also included.
3. Definition of nutritional anemia
The World Health Organization (WHO) defines anemia in the adult as hemoglobin (Hb) con-
centration < 12 g/dL (<120 g/L) for nonpregnant women and <13 g/dL (<130 g/L) for men [2]. 
In elderly, an Hb concentration < 12 g/dL (<120 g/L) is commonly considered as an “estab-
lished” anemia (under strict sense of the academic definition), regardless of the sex of the 
patient [5].
Although low hemoglobin levels (approximately 1 g/dL lower than the WHO standard) are 
often seen with advancing age, anemia (called “unexplained” anemia) should not be assumed 
to be a normal consequence of aging. Several age-related physiological changes such as renal 
insufficiency, stem cell aging, androgen insufficiency, and chronic inflammation may con-
tribute  either to a decline in red blood cell production or shortened red blood cell survival. 
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Age may be associated with compromised hematopoietic reserve and consequently with 
an increased susceptibility to anemia in the presence of hematopoietic stress induced by an 
underlying disorder [6].
In clinical practice, an Hb level <10 g/dL is often considered to be a cut off level where 
investigation in the elderly (“anemia to explore”), and treatment should be performed [7]. 
Indeed, at this Hb level, several recent studies have shown a benefit from investigating the 
anemia and for treating, in regard to the frequency of discovery of a curable etiology [7].
Nutrient-deficiency or nutritional anemia refers to types of anemia that can be directly attributed 
to “nutritional disorders” [4, 8]. Thus, the term nutrient deficiency or nutritional anemia covers 
any anemia resulting from a deficiency of nutrients essential for red blood cell formation, for 
example: iron; vitamins, especially vitamin B9 (folate), but also vitamin B12 (cobalamin) and 
vitamin C (in scurvy), and more rarely, vitamin A, vitamin E, and vitamin B2 (riboflavin), vita-
min B3 (in pellagra), vitamin B6 (pyridoxine); selenium, zinc, and cooper; and protein [8].
4. Prevalence of nutritional anemia
The prevalence of anemia increases with advancing age, especially after age 60–65 years, and 
rises sharply after the age of 80 years [2, 6]. Currently, anemia in this population represents a 
public health problem in developed countries.
In the United States (US), results from the third National Health and Nutrition Examination 
Survey (NHANES III) indicate that the prevalence of anemia among elderly individuals, living 
in towns, aged 75 or more and 85 or more, were 15.7% in men and 10.3% in women and 26.1% 
for men and 20.1% in women, respectively [1]. Survey findings indicate further that most ane-
mia among the middle age and elderly is mild; only 2.8% of women and 1.6% of men had an 
Hb <11 g/dL [9]. Results from the NHANES III also indicate that nutrient-deficiency anemia 
represents at least one-third of all causes of anemia [1].
In the US, results from the Framingham cohort indicate a lower prevalence of anemia among 
1016 subjects within 67–96 years of age. In this group, the prevalence of anemia in men and 
women was 6.1 and 10.5%, respectively [10]. In this study, in addition to anemia of inflammation 
and of renal failure, nutritional anemia was also a major cause of anemia.
In a French nationwide study of 1351 patients hospitalized in several departments of Internal 
Medicine, anemia was present in 874 (65%) patients according to the WHO definition, and 573 
(42%) patients had an Hb level of <11 g/dL (<11 g/L) [11].
5. Etiology of anemia with a focus on nutritional anemia
Because elderly patients often have several associated co-morbid conditions and are commonly 
taking a variety of medications, some of which may contribute to anemia, the precise etiology 
of anemia is frequently difficult to determine, even after extensive investigations, including 
bone marrow biopsy [3, 13]. Thus, according to the literatures and in our own experience, the 
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etiology of anemia can be identified in only approximately 80% of the cases, in spite of the use 
of new tools such as video capsule [7, 14]. Moreover, a significant proportion of elderly anemic 
patients, around 30–50%, are presumed to have multiple causes for their anemia [14, 15]. In 
cases where the causes of anemia have not been established, an inadequate diagnostic work-
up for the patient could be suspected.
In the elderly, causes of anemia are divided into three main broad groups: (1) “nutrient-
deficiency or nutritional anemia,” mainly in relation with iron deficiency anemia; (2) 
“anemia of chronic disease,” including anemia related to renal failure, chronic inflamma-
tion, chronic heart failure; and (3) “unexplained anemia” [2, 3, 9]. In the aforementioned 
NHANES III study, 34% of all anemia in adults and elderly patients were caused by iron, 
vitamin B9 (folate), and vitamin B12 (cobalamin) deficiency, alone or in combination (nutri-
ent-deficiency anemia) [1]. In this study, 12% of all anemia were related, perhaps at least 
associated, with renal insufficiency, 20% with chronic diseases, and in 34% of the cases, the 
cause of anemia remained unexplained.
About 60% of nutritional anemia is associated with iron deficiency and most of those cases 
are the result of chronic blood loss from gastrointestinal lesions in developed countries [1]. 
The remaining cases of nutrient-deficiency anemia are usually associated with vitamin B12 
and/or vitamin B9 deficiency and are easily treated. In Table 1, we report our personal expe-
rience (retrospective study) of the etiology of anemia in 300 hospitalized patients of ≥65 years 
old [4, 7].
Rare unknown causes of nutrient-deficiency anemia include several other vitamin deficiencies 
(e.g., vitamins A, B2, B3, C, and E), selenium, zinc, or cooper [8]. These later etiologies are nev-
ertheless not well-studied in the literature, and to date, few not well-documented data are avail-
able, except for the theoretical and pathological aspects of anemia.
Etiology Prevalence (%)
Chronic inflammation (chronic disease) 23.0
Iron deficiency 18
Renal failure 9




Vitamin B12 deficiency 4
Unexplained causes 21
Table 1.  Etiology of anemia in patients older than 65 years (n = 300), hospitalized in an internal medicine department 
(tertiary reference center) [7].
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6. Iron deficiency anemia in the elderly
Iron deficiency anemia, the most common cause of anemia in the elderly [1], results usu-
ally from chronic gastrointestinal (GI) blood loss mainly caused by esophagitis, gastritis, 
ulcer, related or not related to nonsteroidal anti-inflammatory drug intake, and/or chronic 
Helicobacter pylori infections, varices (portal hypertension), premalignant polyps, colorectal 
cancer, or angiodysplasia [15, 16].
It is important to keep in mind that GI blood loss is often occult and is not ruled out by 
negative fecal blood tests. In elderly, GI tract abnormalities can be identified with appropri-
ate investigations (mainly invasive and require general anesthesia) in the majority of patients 
with iron deficiency anemia [14]. In 40–60% of patients, the source is in the upper GI tract 
and the identified cause of GI blood loss is benign [18, 19]. In 15–30% of patients, the source 
of GI blood loss is in the colon, here also with mainly benign lesions. Table 2 presents our 
experience of the evaluation of the GI tract in 90 patients with chronic blood loss during their 
follow-up in an internal medicine department (in a referral center) [7].
The source of bleeding is not found in the remaining 10–40% of patients with GI blood loss. 
Fortunately, these patients do well with iron replacement and repeated investigation may be 
only proposed in “to good health” elderly patients [15]. In these patients, repeated GI inves-
tigation with upper and/or lower endoscopy and video capsule may be of interest, with the 
detection of the etiology of bleeding in an additional 20% of cases [19, 20]. It is important 
because one-third of the iron deficiency anemia is related to GI malignancies. In our experi-
ence, repeated investigation is not recommended in frailty elderly patients [21].
Etiology Prevalence (%)
Esophagitis and Mallory Weiss syndrome 4.4
Gastritis, atrophic gastritis and ulcer related or not related to NSAID use and/or 
Helicobacter pylori infection
30
Varices related to portal hypertension 9
Angiodysplasia 2.25
Colon diverticula 4.5
Colorectal benign and pre-malignant polyps 5.5
Colorectal cancer 5.5
Inflammatory bowel disease 2.25
Unexplained causes 36.6
NSAID: nonsteroidal anti-inflammatory drug.
Table 2.  Results of the evaluation of the gastrointestinal tract in elderly patients (≥65 years) with chronic blood loss 
(n = 90), hospitalized in an internal medicine department [14].
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H. pylori infection, chronic gastritis (especially atrophic gastritis), and coeliac disease are asso-
ciated with “unexplained GI iron deficiency anemia” [22]. More rarely, large amount of tea (at 
least 2 L/day), vegetarian and theoretically long-term anti-acid medication intake are also asso-
ciated with this condition [15]. In practice, any elderly subject whose dietary intake is poor 
and has recent unexplained weight loss is a candidate for increased medical surveillance [23].
Chronic blood loss from the genitourinary tract and exceptionally from chronic hemoptysis 
may result in iron deficiency [15]. In this situation, bleeding disorders and particularly antico-
agulant and antiplatelet medications may promote the development of iron deficiency in the 
elderly (around 20% in our experience) [7, 14].
7. Vitamin B9 and vitamin B12 deficiency anemia in the elderly
Both vitamin B9 and B12 deficiencies are common among elderly, each occurring in at least 
5% of the patients [15]. The Framingham study demonstrated an incidence of 12% among 
elderly people living in the community [24].
Vitamin B9 deficiency usually develops as a result of inadequate dietary intake and malnutri-
tion, quiet frequent in elderly patients of malabsorption, as in coeliac disease [1, 15]. In fact, 
a regular diet contains 500–700 μg of vitamin B9 and the body contains very little vitamin B9 
with stocks expected to last 4–6 months. The affected patients usually have a history of weight 
loss, poor weight gain, and weakness. This is particularly the case in Alzheimer’s patient or in 
patients with advanced dementia. In addition, several drugs (methotrexate, cotrimoxazole, sul-
fasalazine, anticonvulsants) and alcohol—even in elderly—may cause deficiency of folic acid [7].
In elderly patients, the etiologies of vitamin B12 deficiency are represented primarily by food-
cobalamin malabsorption (FCM) and Biermer’s disease, also called pernicious anemia. The 
FCM is not a real malabsorption in view of physiopathology, but a maldigestion of vitamin 
B12 (linked to food). More rarely, the etiologies of vitamin B12 deficiency include intake defi-
ciency and true malabsorption, related for example, to digestive tract surgery [25]. In a study 
by our group (n = 200), FCM accounted for about 60–70% of the etiologies of vitamin B12 defi-
ciency and about 15–25% in Biermer’s disease [26, 27]. Figure 1 presents the principal causes 
of vitamin B12 deficiency in 172 elderly patients (median age: 70 years) hospitalized in the 
University Hospital of Strasbourg, France [26].
FCM is characterized by the inability to release cobalamin from food and/or intestinal trans-
port proteins, particularly in case of hypochlorhydria, where the absorption of “unbound” 
cobalamin is normal (“mal digestion” of the food-cobalamin) [28]. As we have recently indi-
cated, this syndrome is defined by cobalamin deficiency despite sufficient cobalamin intake 
from food and a normal Schilling test, where the later rules out malabsorption or pernicious 
anemia [29]. FCM is caused primarily by atrophic gastritis [28]. Other factors that commonly 
contribute to FCM in elderly people include chronic carriage and infection of H. pylori; intesti-
nal microbial proliferation; long-term ingestion of antacids (e.g., proton-pump inhibitors), and 
biguanides (metformin); chronic alcoholism; surgery or gastric reconstruction (e.g., bypass 
surgery for obesity); partial and pancreatic exocrine failure [29]. It should be emphasized that 
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Carmel first believed that FCM was associated with moderate cobalamin deficiency, leading 
to only “subtle” clinical symptoms (“subtle cobalamin deficiency”) [30]. However in our experi-
ence, the clinical manifestations of FCM are not very different from those of cobalamin defi-
ciencies associated with other causes, e.g., Biermer’s disease [29].
Biermer’s disease is caused by impaired absorption of vitamin B12 due to the neutralization 
of intrinsic factor action in the setting of immune atrophic gastritis (loss of intrinsic factor in 
genetic form) [4, 25]. In practice, the diagnosis of Biermer’s disease is based on the presence 
of: (i) intrinsic factor antibodies in serum (specificity: >98%, sensibility: around 50%) and/or 
(ii) autoimmune atrophic gastritis (the presence of H. pylori infection in gastric biopsies is an 
exclusion factor) [4, 25]. It is to note that Biermer’s disease is associated with other immuno-
logical diseases, even in the elderly, such as Sjögren’s syndrome, Hashimoto’s disease, type 1 
diabetes mellitus, or coeliac disease.
8. Clinical presentation of nutritional anemia
In elderly patients, the onset of anemic symptoms (fatigue, asthenia) and signs (pallor, palpi-
tations) is usually insidious because majority of these patients adjust their physical activities, 
stay at home, and take several drugs which mask the anemic symptomatology. Thus, these 
symptoms may be overlooked and undiagnosed. [15]. In elderly, anemia may be revealed by 
the exacerbation of chronic-associated conditions or disorders, as dyspnea or edema of the 
legs related to worsening of cardiac failure. Anemia has also been reported to worsen angina, 
cognitive dysfunction related to cerebrovascular insufficiency [6].
In elderly patients, anemia has been associated with an increased risk for mortality, a longer 
hospitalization for elective procedures and a decreased quality of life [6, 31].
Iron, vitamin B9, and vitamin B12 deficiencies may be associated with specific symptoms 



















Figure 1 . Etiologies of cobalamin deficiency in 172 elderly patients hospitalized in the University Hospital of Strasbourg, 
France [25, 29].
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in elderly patients [25]. The features of vitamin B9 deficiency are nearly indistinguish-
able from those of vitamin B12 deficiency, although the symptomatology is generally 
less severe. Iron deficiency is responsible for changes in hair (hair loss), nails (koilony-
chias), glossitis, dermatitis herpetiformis, photodermatitis, restless legs syndrome, and/or 
Plummer’s syndrome [32].
9. Biological abnormalities related to nutritional anemia
Patients with nutritional anemia often have mild to moderate anemia, with Hb levels 
between 8 and 10 g/dL. This anemia is generally hyporegenerative, with a low reticulocyte 
count (<50 × 109/L). This represents the consequence of the reduced activity of the hemato-
poietic system to replace the peripheral blood loss or deficiency [12, 15].
In elderly, the anemia is frequently “normocytic,” with a mean erythrocyte cell volume (MECV) 
between 80 and 100 fL. This normocytic nature of the anemia is related to the multifactorial eti-
ologies of anemia. In exclusive iron deficiency, the erythrocytes are usually “microcytic,” with a 
MECV <80 fL (main differential diagnoses: chronic inflammation, thalassemia). In exclusive vita-
min B9 and/or vitamin B12 deficiency, the erythrocytes are usually “macrocytic,” with a MECV 
>120 fL (main differential diagnosis: alcohol, hypothyroidism, and myelodysplastic syndromes). 
Other hematological abnormalities and manifestations may also be associated with cobalamin 
deficiency as listed in Table 4 [33].
Iron deficiency is documented by a low serum iron level, an increased total iron-binding capacity, 
and a low serum ferritin level (<15 ng/mL) [17]. In cases associated with chronic inflammation, 
the transferrin receptor-ferritin index appears to be the most appropriate parameter to discrimi-
nate between the two disorders [17].
Neuropsychiatric manifestations Digestive manifestations Other manifestations
• Frequent: polyneurites (especially 
sensitive ones), ataxia, Babinski’s 
phenomenon
• Classic: combined sclerosis of the 
spinal cord
• Rare: cerebellar syndromes affecting 
the cranial nerves including optic 
neuritis, optic atrophy, urinary and/or 
fecal incontinence
Under study: changes in the higher func-
tions, even dementia, stroke and ath-
erosclerosis (hyperhomocysteinemia), 
parkinsonian syndromes, depression, 
multiple sclerosis
• Classic: Hunter’s glos-
sitis, jaundice, LDH 
and bilirubin elevation 
(“intramedullary 
destruction”)
• Deba Table: abdomi-
nal pain, dyspepsia, 
nausea, vomiting, diar-
rhea, disturbances in 
intestinal functioning
• Rare: resistant and 
recurring mucocutane-
ous ulcers cobalamin 
deficiency
• Under study: atrophy of the vaginal 
mucosa and chronic vaginal and uri-
nary infections (especially mycosis), 
venous thromboembolic disease, 
angina (hyperhomocysteinemia)
Table 3. Manifestations related to vitamin B12 deficiency (in addition to hematological manifestations) [25].
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Vitamin B12 deficiency is usually documented by a low serum vitamin B12 level (<200 pg/
mL). An increase of the serum methylmalonic acid or homocysteine levels should be estab-
lished to exclude a false negative result for vitamin B12 [30]. In vitamin B9 deficiency, the red 
cell vitamin B9 concentration is the recommended investigation [30].
10. Treatment of nutritional anemia
In iron deficiency anemia, iron supplementation should be initiated in association with the treat-
ment of the underlying cause of bleeding. Treatment of nutritional anemia requires particular 
attention to establish the correct cause in all patients, particularly in elderly patients in a very 
good general condition of the body or mind [15]. Standard therapy for iron deficiency is an oral 
administration of 200–300 mg of ferrous sulfate (60 mg of elemental iron) [34, 35]. Oral iron 
supplementation is usually the first choice for the treatment of iron deficiency anemia because 
of its effectiveness and low cost. Vitamin C enhances iron absorption. Intravenous iron replace-
ment may be reserved for patients with iron deficiency that fails to respond to oral replacement 
Parameters Values
Hemoglobin level (g/dL) 10.3 ± 0.4 (4.9–15.1)
Mean erythrocyte cell volume (fL) 98.9 ± 25.6 (76–142)
Reticulocyte count (%) 15.2 (1–32)
White cell count (/mm3) 6200 ± 4100 (500–20,000)
Platelet count (103/mm3) 146 ± 42 (27–580)
Anemia with Hb level < 12 g/dL 37%
Anemia with Hb level < 6 g/dL 2.5%
Anemia and macrocytosis (MECV >100 fL) 33.8%
Isolated macrocytosis (MECV >100 fL) 17%
Microcytosis (MECV <80 fL) 5%
White cell count <4000/mm3 14%
Neutrophil count <1000/mm3 3%
Thrombopenia (<150 × 103/mm3) 10%
Neutrophil hypersegmentation 32%
Megaloblastosis 60%
Life threatening manifestations 9%
MECV: mean erythrocyte cell volume.
Table 4. Hematological manifestations in patients with documented cobalamin deficiency (n = 201), hospitalized in an 
internal medicine department (tertiary reference center) [33].
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or in patients with documented malabsorption, inflammatory bowel diseases, malignancies, 
renal failure, and also perhaps in anemic patients with chronic heart failure. Parenteral iron 
supplementation may also be used when there is an intolerance or noncompliance with oral 
preparations. Intravenous iron sucrose is reasonably well tolerated, even when administered in 
boluses [35].
In elderly patients, vitamin B12 deficiency anemia may be treated by vitamin B12 supplementa-
tion, parenterally (commonly intramuscular) or orally [36, 37]. Our team (CAREnce en vitamine 
B12 [Care B12]) in the University Hospital of Strasbourg (France) has developed an effective oral 
treatment for cobalamin deficiency. The main results of our protocol of oral cobalamin therapy 
studies are summarized in Table 5 [36] A systematic review conducted under the auspices of the 
Cochrane Metabolic and Endocrine Disorders Review Group also supports the efficacy of oral cobala-
min therapy, with: (1) a daily dose of 2000 and 1000 μg for 1 month of crystalline cyanocobalamin 
Study characteristics  
(number of patients)
Therapeutic modalities Results
Open prospective study of 
well-documented vitamin B12 
deficiency related to food-
cobalamin malabsorption (n = 10)
Oral crystalline cyanocobalamin: 
650 μg/day, during the condition 
and continue at least 3 months
• Normalization of serum vitamin B12 
levels in 80% of the patients
• Significant increase of Hb levels 
(mean of 1.9 g/dL) and decrease of 
MECV (mean of 7.8 fL)
Open prospective study of low 
vitamin B12 levels not related to 
pernicious anemia (n = 20)
Oral crystalline cyanocobalamin: 
1000 μg/day during the condition 
and continue at least 1 week
• Normalization of serum vitamin B12 
levels in 85% of the patients
Open prospective study of 
well-documented vitamin B12 
deficiency related to food-
cobalamin malabsorption (n = 30)
Oral crystalline cyanocobalamin: 
between 1000 and 250 μg/day, 
during the condition and continue at 
least 1 month
• Normalization of serum vitamin B12 
levels in 87% of the patients
• Significant increase of Hb levels 
(mean of 0.6 g/dL) and decrease of 
MECV (mean of 3 fL); normalization 
of Hb levels and MECV in 54 and 
100% of the patients, respectively
• Dose effect–effectiveness dose of 
vitamin B12 ≥500 μg/day
Open prospective study of low 
vitamin B12 levels not related to 
pernicious anemia (n = 30)
Oral crystalline cyanocobalamin: 
between 1000 and 125 μg/day 
during the condition and continue at 
least 1 week
• Normalization of serum vitamin B12 
levels in all patients with at least a 
dose of vitamin ≥250 μg/day
• Dose effect–effectiveness dose of 
vitamin B12 ≥500 μg/day
Open prospective study of low 
vitamin B12 levels related to 
pernicious anemia (n = 10)
Oral crystalline cyanocobalamin: 
1000 μg/day, during the condition 
and continue at least 3 months
• Significant increase of serum vitamin 
B12 levels in 90% of the patients 
(mean of 117.4 pg/mL
• Significant increase of Hb levels 
(mean of 2.45 g/dL) and decrease of 
MECV (mean of 10.4 fL)
Hb: hemoglobin; MECV: mean erythrocyte cell volume.
Table 5. Study by our team on oral cobalamin therapy: Results on hematological manifestations [36].
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for FCM and Biermer’s disease; and (2) thereafter, a weekly dose between 2000 and 1000 μg of 
vitamin B12 for FCM and a daily dose of 1000 μg (for all the life) in case of Biermer’s disease [37].
In vitamin B9 deficiency, therapeutic doses of vitamin B9 vary between 1 and 5 mg/day [38]. 
Usually, supplementation is continued for at least 3–6 months, provided that the underlying 
causes of the deficiencies have been corrected.
Food sources of nutrients are best for prevention of nutritional anemia, but often supple-
mentation is necessary, especially for the elderly [39]. The USA National Academy of Sciences 
recommends that vitamin B9 and vitamin B12 standardized supplementation should be done 
(fortified cereal) in elderly.
11. Conclusions
In elderly patients, nutritional anemia represents 30–40% of all anemia. About two-third of 
this nutritional anemia is related to iron deficiency. Iron deficiency anemia is mainly the result 
of chronic blood loss from gastrointestinal lesions (with benign lesions in two-third of the 
cases). The remaining cases of nutritional anemia are usually associated with vitamin B12 
and/or vitamin B9 deficiency. In elderly patients, vitamin B12 deficiency is most frequently 
related to food-cobalamin malabsorption; vitamin B9 is related to inadequate dietary intake 
or malnutrition, several drugs (as methotrexate, cotrimoxazole) and chronic alcohol intake. 
Treatment of nutritional anemia is simple and involves replacement of the deficient nutrient 
but requires particular attention to discerning the cause.
Conflict of interest
None related to the content of the present chapter.
Author details
Emmanuel Andrès
Address all correspondence to: emmanuel.andres@chru-strasbourg.fr
Departments of Internal Medicine, Diabetes and Metabolic Disorders, University Hospital of 
Strasbourg, Strasbourg, France
References
[1] National Health and Nutrition Examination Survey. Anthropometric Reference Data, 
United States. 1988-1994. Available from: http://www.cdc.gov/nchs/about/major/nhanes/
Anthropometric%20Measures. [Accessed: January 7, 2016]
Nutritional Anemia in Elderly Patients of Developed Countries
http://dx.doi.org/10.5772/intechopen.70566
115
[2] Eisenstaedt R, Penninx BW, Woodman RC. Anemia in the elderly: Current understand-
ing and emerging concepts. Blood Reviews. 2006;20:213-226
[3] Woodman R, Ferrucci L, Guralnik J. Anemia in older adults. Current Opinion in Hematology. 
2005;12:123-128
[4] Andrès E, Federici L, Serraj K, Kaltenbach G. Update of nutrient-deficiency anemia in 
elderly patients. European Journal of Internal Medicine. 2008;19:488-493
[5] Izaks GJ, Westendorp RG, Knook DL. The definition of anemia in older persons. Journal 
of the American Medical Association. 1999;281:1714-1717
[6] Balducci L, Ershler WB, Krantz S. Anemia in the elderly. Clinical findings and impact on 
health. Critical Reviews in Oncology/Hematology. 2006;58:156-165
[7] Andrès E, Serraj K, Federici L, Vogel T, Kaltenbach G. Anemia in elderly patients: New 
insight into an old disorder. Geriatrics & Gerontology International. 2013;13:519-527
[8] Fishman SM, Christian P, Keith PW. The role of vitamins in the prevention and control 
of anaemia. Public Health Nutrition. 2000;3:125-150
[9] Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia 
in persons 65 years and older in the United States: Evidence for a high rate of unex-
plained anemia. Blood. 2004;104:2263-2268
[10] Fleming DJ, Jacques PF, Tucker KL, Massaro JM, D’Agostino RB, Wilson PW, et al. Iron 
status of the free-living, elderly Framingham heart study cohort: An iron-replete popu-
lation with a high prevalence of elevated iron stores. The American Journal of Clinical 
Nutrition. 2001;73:638-646
[11] Terrier B, Resche-Rigon M, Andrès E, Bonnet F, Hachulla E, Marie I, et al., on behalf of 
the Groupe de Recherche sur les Anémies en Médecine Interne (GRAMI). Prevalence, 
characteristics and prognostic significance of anemia in daily practice: Results from 
a French nationwide cross-sectional and prospective longitudinal study. Quarterly 
Journal of Medicine: An International Journal of Medicine. 2012;105:345-354
[12] Carmel R. Anemia and aging: An overview of clinical, diagnostic and biological issues. 
Blood Reviews. 2001;15:9-18
[13] Joosten E, Pelemans W, Hiele M, Noyen J, Verhaeghe R, Boogaerts MA. Prevalence and 
causes of anaemia in a geriatric hospitalization population. Gerontology. 1992;38:111-117
[14] Petrosyan I, Blaison G, Andrès E, Federici L. Anemia in the elderly: Etiologic profile in 
a prospective cohort of 95 hospitalized patients. European Journal of Internal Medicine. 
2012;23:524-528
[15] Smith DL. Anemia in the elderly. American Family Physician. 2000;62:1565-1572
[16] Suzuki H, Marshall BJ, Hibi T. Overview: Helicobacter pylori and extragastric disease. 
International Journal of Hematology. 2006;84:291-300
Current Topics in Anemia116
[17] Rimon E, Levy S, Sapir A, Gelzer G, Peled R, Ergas D, et al. Diagnosis of iron deficiency 
anemia in the elderly by transferrin receptor-ferritin index. Archives of Internal Medicine. 
2002;162:445-449
[18] Rockey DC. Occult and obscure gastrointestinal bleeding: Causes and clinical manage-
ment. Nature Reviews. Gastroenterology & Hepatology. 2010;7:265-279
[19] Liu K, Kaffes AJ. Iron deficiency anaemia: A review of diagnosis, investigation and man-
agement. European Journal of Gastroenterology & Hepatology. 2012;24:109-116
[20] Muhammad A, Vidyarthi G, Brady P. Role of small bowel capsule endoscopy in the 
diagnosis and management of iron deficiency anemia in elderly: A comprehensive 
review of the current literature. World Journal of Gastroenterology. 2014;20:8416-8423
[21] Camaschella C. Iron-deficiency anemia. The New England Journal of Medicine. 2015;372: 
1832-1843
[22] Nahon S, Lahmek P, Massard J, Lesgourgues B, Mariaud de Serre N, Traissac L, et al. 
Helicobacter pylori-associated chronic gastritis and unexplained iron deficiency anemia: 
A reliable association? Helicobacter. 2003;8:573-577
[23] Milman N, Pedersen AN, Ovesen L, Schroll M. Iron status in 358 apparently healthy 
80- year-old Danish men and women: Relation to food composition and dietary and 
supplemental iron intake. Annals of Hematology. 2004;83:423-429
[24] Lindenbaum J, Rosenberg IH, Wilson PW, Tabler SP, Allen RH. Prevalence of cobala-
min deficiency in the Framingham elderly population. The American Journal of Clinical 
Nutrition. 1994;60:2-11
[25] Andrès E, Loukili NH, Noel E, Kaltenbach G, Ben Abdelgheni M, Perrin AE, et al. 
Vitamin B12 (cobalamin) deficiency in elderly patients. Canadian Medical Association 
Journal. 2004;171:251-260
[26] Andrès E, Affenberger S, Vinzio S, Kurtz JE, Noel E, Kaltenbach G, et al. Food-cobalamin 
malabsorption in elderly patients: Clinical manifestations and treatment. The American 
Journal of Medicine. 2005;118:1154-1159
[27] Andrès E, Perrin AE, Demangeat C, Kurtz JE, Vinzio S, Grunenberger F, et al. The syndrome 
of food-cobalamin malabsorption revisited in a Department of Internal Medicine. A mono-
centric cohort study of 80 patients. European Journal of Internal Medicine. 2003;14:221-226
[28] Carmel R. Malabsorption of food-cobalamin. Bailliere’s Clinical Haematology. 1995;8: 
639-655
[29] Andrès E, Serraj K, Mecili M, Kaltenbach G, Vogel T. The syndrome of food-cobalamin 
malabsorption: A personal view in a perspective of clinical practice. Journal of Blood 
Disorders and Transfusion. 2011;2:108. DOI: 10.4172/2155-9864.1000108
Nutritional Anemia in Elderly Patients of Developed Countries
http://dx.doi.org/10.5772/intechopen.70566
117
[30] Carmel R. Diagnosis and management of clinical and subclinical cobalamin deficiencies: 
Why controversies persist in the age of sensitive metabolic testing. Biochimie. 2013;95: 
1047-1055
[31] Gabrilove J. Anemia and the elderly: Clinical considerations. Best Practice Research & 
Clinical Haematology. 2005;18:417-422
[32] Sato S. Iron deficiency: Structural and microchemical changes in hair, nails, and skin. 
Seminars in Dermatology. 1991;10:313-319
[33] Federici L, Loukili NH, Zimmer J, Affenberger S, Maloisel F, Andrès E. Manifestations 
hématologiques de la carence en vitamine B12: données personnelles et revue de la lit-
térature. La Revue de Médecine Interne. 2007;28:225-231
[34] Umbreit J. Iron deficiency: A concise review. American Journal of Hematology. 2005;78: 
225-231
[35] Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intrave-
nous iron preparations: Systematic review and meta-analysis. Mayo Clinic Proceedings. 
2015;90:12-23
[36] Andrès E. Oral cobalamin (vitamin B12) therapy: From empiricism and personal experi-
ence to evidence based medicine and perspective of recommendations and guideline. 
Journal of Blood Disorders and Transfusion. 2012;3:e102. DOI: 10.4172/2155-9864.1000e102
[37] Vidal-Alaball J, Butler CC, Cannings-John R, Goringe A, Hood K, McCaddon A, et al. 
Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane 
Database of Systematic Reviews. 2005;20:CD004655
[38] Wickramasinghe SN. Diagnosis of megaloblastic anaemias. Blood Reviews. 2006;20: 
299-318
[39] Yen PK. Nutritional anemia. Geriatric Nursing. 2000;21:111-112
Current Topics in Anemia118
